MASI: Masimo Corp.
About
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Current Value
$162.661 Year Return
Current Value
$162.661 Year Return
Key Details
Market Cap
$8.75B
P/E Ratio
112.22
1Y Stock Return
73.22%
1Y Revenue Growth
-3.48%
Dividend Yield
0.00%
Price to Book
6.0
Strategies that include MASI
Stock's related to MASI
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KOS | 0.01% | $1.85B | -42.25% | 0.00% |
| COF | -0.03% | $69.05B | +71.11% | 1.32% |
| COUR | -0.04% | $1.08B | -64.26% | 0.00% |
| NMM | 0.04% | $1.58B | +126.51% | 0.38% |
| LLY | -0.07% | $692.74B | +23.14% | 0.71% |
| XP | 0.08% | $9.15B | -27.16% | 0.00% |
| SRE | -0.08% | $59.15B | +28.15% | 2.62% |
| LKQ | -0.08% | $9.77B | -17.44% | 3.20% |
| IMO | 0.09% | $39.72B | +31.84% | 2.23% |
| DLB | -0.10% | $6.76B | -16.58% | 1.69% |
| WMT | 0.11% | $696.11B | +66.69% | 1.38% |
| TTEC | -0.11% | $204.76M | -76.19% | 1.39% |
| TK | 0.12% | $728.26M | +11.06% | 0.00% |
| HAIN | 0.13% | $663.83M | -31.73% | 0.00% |
| QTTB | -0.14% | $354.34M | +188.64% | 0.00% |
| LBRDK | -0.14% | $12.37B | +4.89% | 0.00% |
| CLMT | -0.14% | $1.79B | +35.14% | 0.00% |
| HAL | 0.14% | $26.77B | -20.26% | 2.20% |
| KOF | -0.15% | $4.13B | -7.43% | 4.24% |
| SAM | -0.15% | $3.58B | -7.64% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SGC | -22.76% | $261.95M | +41.61% | 4.32% |
| ASC | -20.43% | $517.16M | -7.62% | 8.45% |
| KD | -18.52% | $6.51B | +55.09% | 0.00% |
| INSW | -18.20% | $2.07B | +1.70% | 1.14% |
| NNVC | -17.14% | $19.66M | +25.69% | 0.00% |
| LFWD | -16.50% | $16.21M | -63.99% | 0.00% |
| CRCT | -15.71% | $1.12B | -19.90% | 1.91% |
| PGR | -13.58% | $149.10B | +57.29% | 0.45% |
| SOC | -13.49% | $1.93B | +74.70% | 0.00% |
| CPSH | -13.34% | $20.70M | -40.13% | 0.00% |
| PETS | -13.34% | $93.60M | -41.21% | 0.00% |
| IRBT | -13.28% | $220.33M | -75.58% | 0.00% |
| TPST | -12.73% | $37.75M | -77.59% | 0.00% |
| BBVA | -12.66% | $56.78B | +9.42% | 7.49% |
| CYD | -12.50% | $364.46M | -2.94% | 4.26% |
| NVO | -11.85% | $342.62B | -0.15% | 1.40% |
| RVP | -11.55% | $17.51M | -46.82% | 0.00% |
| AOSL | -11.27% | $933.92M | +47.50% | 0.00% |
| CMBT | -11.07% | $2.46B | -29.63% | 13.05% |
| OPAD | -11.04% | $100.74M | -60.81% | 0.00% |
ETF's related to MASI
News
Yahoo
IRVINE, Calif., November 14, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
Yahoo
IRVINE, Calif., November 13, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
Yahoo
Key Insights The projected fair value for Masimo is US$302 based on 2 Stage Free Cash Flow to Equity Masimo's US$168...
Yahoo
Masimo ( NASDAQ:MASI ) Third Quarter 2024 Results Key Financial Results Revenue: US$504.6m (up 5.4% from 3Q 2023). Net...
Yahoo
MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.
Yahoo
Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.